国家淋球菌耐药监测哨点实施方案(2019年试行版)

Protocol for National Gonococcal Resistance Surveillance Programme in China(Pilot version in 2019)

中国淋球菌耐药监测系统于1987年启动,当时仅是包括少量门诊的合作项目。该项目于1992年加入WHO西太区淋球菌抗菌药物敏感性监测项目,至2018年底监测点覆盖了全国11个省份。2019年,该中心根据WHO及我国耐药监测相关文件要求,在原有实施方案的基础上进一步完善了中国淋球菌耐药监测系统,修订了《国家淋球菌耐药监测哨点实施方案》。本实施方案增加了临床流行病学的调查及新加监测药物等,为及时掌握我国淋球菌耐药发展的趋势、制定我国淋球菌耐药控制策略及新药开发提供科学数据,并将根据淋球菌国内外最新的耐药趋势及项目实施过程出现的问题进行定期的更新及修订。

The National Gonococcal Resistance Surveillance Programme in China (China-GRSP) was launched by the National Center for Sexually Transmitted Disease Control (NCSTD) as a collaboration project consisting of a few clinics in the country in 1987.The China-GRSP joined the WHO Western Pacific Gonococcal Antimicrobial Susceptibility Programme (GASP) in 1992 and then expanded gradually to more participating clinics to eventually cover eleven provinces by 2018.In 2019,according to the related documents about drug resistance surveillance from WHO and China,we improve the GRSP and revise the new edition of China-GRSP.This programme will improve the quality and increase the coverage,including replenishing clinical epidemiological investigation and new monitoring drugs,and reaching nearly two-thirds of the provinces in China,so as to understand the trend of gonococcal resistance in China and provide scientific data for formulating drug resistance control strategy and the development of new drug for gonorrhea in China.This protocol is an extension of the original protocol and will be updated regularly according to the latest clinical evidence.